tiprankstipranks
NKGen Biotech Korea Co., Ltd. (KR:182400)
:182400
South Korea Market

NKGen Biotech Korea Co., Ltd. (182400) Price & Analysis

Followers

182400 Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

182400 FAQ

What was NKGen Biotech Korea Co., Ltd.’s price range in the past 12 months?
Currently, no data Available
What is NKGen Biotech Korea Co., Ltd.’s market cap?
NKGen Biotech Korea Co., Ltd.’s market cap is ₩172.74B.
    When is NKGen Biotech Korea Co., Ltd.’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were NKGen Biotech Korea Co., Ltd.’s earnings last quarter?
    NKGen Biotech Korea Co., Ltd. released its earnings results on May 15, 2026. The company reported -$17.538 earnings per share for the quarter, missing the consensus estimate of N/A by -$17.538.
      Is NKGen Biotech Korea Co., Ltd. overvalued?
      According to Wall Street analysts NKGen Biotech Korea Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does NKGen Biotech Korea Co., Ltd. pay dividends?
        NKGen Biotech Korea Co., Ltd. does not currently pay dividends.
        What is NKGen Biotech Korea Co., Ltd.’s EPS estimate?
        NKGen Biotech Korea Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does NKGen Biotech Korea Co., Ltd. have?
        NKGen Biotech Korea Co., Ltd. has 72,342,430 shares outstanding.
          What happened to NKGen Biotech Korea Co., Ltd.’s price movement after its last earnings report?
          NKGen Biotech Korea Co., Ltd. reported an EPS of -$17.538 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
            Which hedge fund is a major shareholder of NKGen Biotech Korea Co., Ltd.?
            Currently, no hedge funds are holding shares in KR:182400
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              NKGen Biotech Korea Co., Ltd. (182400) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Bioneer Corporation
              Anterogen Co., Ltd.
              GC CELL CORPORATION
              ALMAC Co., Ltd.
              3billion, Inc.
              Popular Stocks